Paper28596809
Viscum album (L.) in experimental animal tumors: A meta-analysis.
Bonamin LV and 2 others. Exp Ther Med, 2017. Cited by 14 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Viscum album (L.) in experimental animal tumors: A meta-analysis. Papers, record 28596809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28596809
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19,945,681 | Reporting experiments in homeopathic basic research (REHBaR)--a detailed guideline for authors. | Homeopathy | 2009 | https://conductscience.org/library/papers/19945681 | PubMed |
| 2 | 24,250,214 | How to calculate sample size in animal studies? | J Pharmacol Pharmacother | 2013 | https://conductscience.org/library/papers/24250214 | PubMed |
| 3 | 11,131,663 | Antitumoral effects of an intravesically applied aqueous mistletoe extract on urinary bladder carcinoma MB49 in mice. | Anticancer Res | 2000 | https://conductscience.org/library/papers/11131663 | PubMed |
| 4 | 11,448,531 | Application of standardized mistletoe extracts augment immune response and down regulates metastatic organ colonization in murine models. | Cancer Lett | 2001 | https://conductscience.org/library/papers/11448531 | PubMed |
| 5 | 19,788,934 | Immunomodulating effects of Korean mistletoe lectin in vitro and in vivo. | Int Immunopharmacol | 2009 | https://conductscience.org/library/papers/19788934 | PubMed |
| 6 | 11,576,848 | Immunotherapy of C3H/HeJ mammary adenocarcinoma with interleukin-2, mistletoe lectin or their combination. effects on tumour growth, capillary leakage and nitric oxide (NO) production. | Eur J Cancer | 2001 | https://conductscience.org/library/papers/11576848 | PubMed |
| 7 | 15,270,843 | Anti-inflammatory effect of Viscum album agglutinin-I (VAA-I): induction of apoptosis in activated neutrophils and inhibition of lipopolysaccharide-induced neutrophilic inflammation in vivo. | Clin Exp Immunol | 2004 | https://conductscience.org/library/papers/15270843 | PubMed |
| 8 | 10,704,739 | Recombinant mistletoe lectin (rML) is successful in treating human ovarian cancer cells transplanted into severe combined immunodeficient (SCID) mice. | Cancer Lett | 2000 | https://conductscience.org/library/papers/10704739 | PubMed |
| 9 | 9,730,252 | Prophylactic effect of Korean mistletoe (Viscum album coloratum) extract on tumor metastasis is mediated by enhancement of NK cell activity. | Int J Immunopharmacol | 1998 | https://conductscience.org/library/papers/9730252 | PubMed |
| 10 | 10,741,906 | Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response. | J Cancer Res Clin Oncol | 2000 | https://conductscience.org/library/papers/10741906 | PubMed |
| 11 | 23,614,029 | Triterpenoids amplify anti-tumoral effects of mistletoe extracts on murine B16.f10 melanoma in vivo. | PLoS One | 2013 | https://conductscience.org/library/papers/23614029 | PubMed |
| 12 | 27,272,001 | [Study for the treatment of nonmuscle invasive bladder cancer : A phase III efficacy trial for intravesical instillation of mistletoe extract in superficial bladder cancer (TIM) - AB 40/11 of the AUO]. | Urologe A | 2016 | https://conductscience.org/library/papers/27272001 | PubMed |
| 13 | 9,314,050 | Lack of an antitumoral effect of immunomodulatory galactoside-specific mistletoe lectin on N-methyl-N-nitrosourea-induced urinary bladder carcinogenesis in rats. | Exp Toxicol Pathol | 1997 | https://conductscience.org/library/papers/9314050 | PubMed |
| 14 | 16,412,563 | Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma. | Cancer Lett | 2006 | https://conductscience.org/library/papers/16412563 | PubMed |
| 15 | 2,345,458 | Effect of a preparation from Viscum album on tumor development in vitro and in mice. | J Ethnopharmacol | 1990 | https://conductscience.org/library/papers/2345458 | PubMed |
| 16 | 9,179,362 | The Viscum album preparation Isorel inhibits the growth of melanoma B16F10 by influencing the tumour-host relationship. | Anticancer Drugs | 1997 | https://conductscience.org/library/papers/9179362 | PubMed |
| 17 | 25,910,967 | Mistletoe Plant Extract in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Phase Ib/IIa Single Group Dose Escalation Study. | J Urol | 2015 | https://conductscience.org/library/papers/25910967 | PubMed |
| 18 | 9,179,364 | Viscum album L. preparation Isorel modifies the immune response in normal and in tumour-bearing mice. | Anticancer Drugs | 1997 | https://conductscience.org/library/papers/9179364 | PubMed |
| 19 | 11,801,684 | Mechanisms involved in spontaneous and Viscum album agglutinin-I-induced human neutrophil apoptosis: Viscum album agglutinin-I accelerates the loss of antiapoptotic Mcl-1 expression and the degradation of cytoskeletal paxillin and vimentin proteins via caspases. | J Immunol | 2002 | https://conductscience.org/library/papers/11801684 | PubMed |
| 20 | 9,261,741 | Effect of viscum album in the inhibition of lung metastasis in mice induced by B16F10 melanoma cells. | J Exp Clin Cancer Res | 1997 | https://conductscience.org/library/papers/9261741 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37,754,510 | Mistletoe Extracts during the Oncological Perioperative Period: A Systematic Review and Meta-Analysis of Human Randomized Controlled Trials. | Curr Oncol | 2023 | https://conductscience.org/library/papers/37754510 | PubMed |
| 37,622,692 | Traditional Uses, Phytochemical Constituents and Ethnopharmacological Properties of Mistletoe from Phoradendron and Viscum Species. | Comb Chem High Throughput Screen | 2024 | https://conductscience.org/library/papers/37622692 | PubMed |
| 37,514,321 | The Antioxidant Activity of Mistletoes (Viscum album and Other Species). | Plants (Basel) | 2023 | https://conductscience.org/library/papers/37514321 | PubMed |
| 37,176,869 | A Scoping Review of Genus Viscum: Biological and Chemical Aspects of Alcoholic Extracts. | Plants (Basel) | 2023 | https://conductscience.org/library/papers/37176869 | PubMed |
| 37,050,086 | The Anti-Inflammatory Activity of Viscum album. | Plants (Basel) | 2023 | https://conductscience.org/library/papers/37050086 | PubMed |
| 35,988,582 | In-Vitro Growth Kinetics of Mesenchymal Stem Cells in Cytotoxicity Tests Using Low-Diluted Viscum Album. | Homeopathy | 2023 | https://conductscience.org/library/papers/35988582 | PubMed |
| 34,451,771 | Metabolomics by UHPLC-Q-TOF Reveals Host Tree-Dependent Phytochemical Variation in Viscum album L. | Plants (Basel) | 2021 | https://conductscience.org/library/papers/34451771 | PubMed |
| 33,776,708 | Mistletoe Extract Viscum Fraxini-2 for Treatment of Advanced Hepatocellular Carcinoma: A Case Series. | Case Rep Oncol | 2021 | https://conductscience.org/library/papers/33776708 | PubMed |
| 32,887,375 | Comprehensive Metabolome Analysis of Fermented Aqueous Extracts of Viscum album L. by Liquid Chromatography-High Resolution Tandem Mass Spectrometry. | Molecules | 2020 | https://conductscience.org/library/papers/32887375 | PubMed |
| 32,646,417 | Phytochemical analysis and in vitro anti-proliferative activity of Viscum album ethanolic extracts. | BMC Complement Med Ther | 2020 | https://conductscience.org/library/papers/32646417 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28596809
GET https://conductscience.org/api/papers/v1/28596809/references?page=2